COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
2021 · Leukemia · 94 citations
https://doi.org/10.1038/s41375-021-01450-8
M
Moritz Fürstenau
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
1.3K
Citations
18
h-index
27
i10-index
Moritz Fürstenau is an academic researcher from Düsseldorf University Hospital. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 18, co-authored 82 publications.
ORCID: 0000-0002-6593-0140Papers by this author
worksFirst-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
2024 · The Lancet Oncology · 66 citations
https://doi.org/10.1016/s1470-2045(24)00196-7
The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>
2023 · American Journal of Hematology · 21 citations
https://doi.org/10.1002/ajh.27093
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial
2025 · Blood · 7 citations
https://doi.org/10.1182/blood.2024026685
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial
2024 · Journal of Clinical Oncology · 6 citations
https://doi.org/10.1200/jco.24.00975
CLL-465 Second Primary Malignancies (SPMs) in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With the Combination of a Targeted Agent With an Antibody in 4 Phase 2 Trials of the German CLL Study Group (GCLLSG)
2024 · Clinical Lymphoma Myeloma & Leukemia · 1 citations
https://doi.org/10.1016/s2152-2650(24)01282-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat